Presentations Explore ARIA with the Use of Antiplatelets or Anticoagulants and Isolated ARIA-H in Patients from Eisai’s Lecanemab Phase 3 Confirmatory Clarity AD Study in Early Alzheimer’s Disease TOKYO, March 22, 2023 /PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo…

DUBLIN, March 22, 2023 /PRNewswire/ — The “Global Omega-3 Product Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type, Source, Application, and Region” report has been added to ResearchAndMarkets.com’s offering. According to publisher estimates, the Global…

NEW YORK, March 22, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Alico, Inc. (NASDAQ: ALCO) between February 4, 2021 and December 13, 2022, both dates inclusive (the…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.